HeadlinesBriefing favicon HeadlinesBriefing.com

Danone Sales Growth Amid Formula Recalls and Strategic Moves

Bloomberg Markets •
×

Danone SA sales rose 2.7% in Q1 as demand for Activia yogurt and Evian water offset infant formula recall costs. Like-for-like sales beat analyst estimates, driven by protein-rich products and GLP-1 drug trends. CEO Antoine de Saint-Affrique’s strategy of divesting underperforming assets and acquiring Huel—a UK meal-replacement shake maker—has revitalized growth.

Revenue from specialized nutrition in Europe dipped due to recalls and Middle East conflicts, but Asia-Pacific regions surged. The €70 million recall cost highlights risks, yet full-year guidance remains intact.